Articles related to CARDIOMETABOLIC HEALTH

A meta-analysis of 99 randomized controlled trials suggests that vitamin D supplementation may offer significant cardiometabolic benefits, with the greatest improvements seen in specific population subgroups.

A randomized controlled trial involving 108 adults with metabolic syndrome found that implementing an 8- to 10-hour time-restricted eating window, in addition to standard-of-care treatments, resulted in a 0.10% reduction in HbA1c levels compared to standard care alone.

Moderate caffeine intake (200-300 mg per day) was associated with a 40.7% lower risk of new-onset cardiometabolic multimorbidity compared to non-consumers or those consuming less than 100 mg daily.